RKLB — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-05-07

• We continue to make significant progress in the development of the Neutron launch vehicle. Neutron qualification testing of flight hardware from large structures through to component level systems is ongoing. During Q1, we achieved significant milestones across the Neutron program with ongoing integ…

• Revenue per launch represents the average transaction price attributable to launch contract performance obligations during the period in which the launch occurs, regardless of whether the revenue is recognized using the point-in-time or over-time method of revenue recognition. This metric provides i…

• For the three months ended March 31, 2026 and 2025, revenue per launch was $9.3 million and $7.1 million, respectively. Meanwhile, cost per launch for the three months ended March 31, 2026 and 2025 was $5.4 million and $5.7 million, respectively. The increase in revenue per launch reflects changes i…

• Backlog represents future revenues that we would recognize in connection with the completion of all contracts and purchase orders that have been entered into by our customers but have not yet been fulfilled, excluding any customer options for future products or services that have not yet been exerci…

• Interest expense consists primarily of interest expense on our loan agreements, amortization of debt issuance costs and finance lease interest.

Text removed vs the prior filing · source: 10-Q · 2025-11-10

• On September 25, 2025, we entered into a Stock Purchase Agreement (together with the ancillary documents thereto, the “Mynaric Purchase Agreement”), by and among the Company, Rocket Lab USA (“Buyer”), OC III LVS LIII LP, a Delaware limited partnership (“OC III”) and CO Finance II LVS I LLC, a Delawa…

• Pursuant to the terms of the Mynaric Purchase Agreement, all of the issued and outstanding ordinary shares of Mynaric will be purchased in exchange for aggregate consideration of $75 million, consisting of cash or common stock, at our discretion, subject to adjustments at closing (the “Mynaric Trans…

• The Mynaric Purchase Agreement contains representations, warranties, covenants and closing conditions from and for the benefit of each of us and the Sellers that are customary for transactions of this kind. We have also agreed to file a resale registration statement with respect to our common stock …

• Beginning in early April 2025, there has been a significant shift in United States (“U.S.”) trade policy, characterized by increased tariffs and the introduction of new tariffs that could affect our supply chain and business operations. While much of our production is completed in the U.S. and many …

• The ongoing U.S. government shutdown, which began on October 1, 2025, has affected our business operations. A significant portion of our revenues and cash flow are derived from U.S. government contracts, the shutdown has and continues cause delays in anticipated contract awards and payments. We are …

Text added vs the prior filing · source: 10-Q · 2026-05-07

• Relying on many of the same allegations as the securities class action, in April 2025, two shareholders filed putative shareholder derivative actions on behalf of the Company against its directors and certain of its officers in the United States District Court for the Central District of California.…

• The Company intends to vigorously defend itself against these claims and is currently unable to predict the timing, outcome or consequences of these actions, or estimate any probable range of loss.

Text added vs the prior filing · source: 10-Q · 2026-05-07

• (1) Represents shares issuable to Mr. Spice upon the exercise of approximately 33% of the vested stock options held by Mr. Spice as of the date of the Rule 10b5-1 Trading Plan, all of which are scheduled to expire in August 2028.

Text removed vs the prior filing · source: 10-Q · 2025-11-10

• Adam SpiceChief Financial OfficerSeptember 19, 2025January 5, 20261,365,665

• Arjun KampaniSenior Vice President, General Counsel and Corporate SecretarySeptember 19, 2025March 4, 2026132,519

• Frank KleinChief Operations OfficerSeptember 19, 2025January 2, 2026425,000

• (1) Represents 634,335 shares held by Mr. Spice and 731,330 shares issuable to Mr. Spice upon the exercise of approximately 22% of the vested stock options held by Mr. Spice as of the date of the Rule 10b5-1 Trading Plan, all of which are scheduled to expire in August 2028.

• (2) The aggregate number of shares issuable upon the vesting and settlement of restricted stock units (“RSUs”) that will be available for sale under the Rule 10b5-1 Trading Plan is not yet determinable because the shares available will be net of shares sold to satisfy tax withholding obligations tha…